Health Action International
Jacob van Lennepkade 334-T
1053 NJ Amsterdam
The Netherlands

Tel: +31 (0)20 683 3684
Fax: +31 (0)20 685 5002
E-mail: info@haiweb.org

Employment Opportunities

Mission Statement

Global Annual Report (2005)

Annual Accounts (2006)

Member Organisations

List of Donors

 
Pharmageddon?

Pharmageddon? Is a hypothesis. Pharmageddon? describes "the prospect of a world in which medicines and medicine produce more ill-health than health, and when medical progress does more harm than good".
Click here to find out more.

By way of stimulating enquiry, consultation and worthwhile peer review, Social Audit is offering at least eight prizes of €1,000 each for any responses (up to 350 words). See: Call for Abstracts

The Allen Lane Foundation has just awarded Social Audit a grant of £10,000 (€15,000) to explore Pharmageddon - “the prospect of a world in which medicines and medicine produce more ill-health than health, and when medical progress does more harm than good”.

  We applied for this grant specifically to be able to offer attractive prizes/grants for the best submissions (Abstracts) for the inaugural conference on Pharmageddon? to be organised jointly with Health Action International (Europe) in 2008.

  The rules of this competition are simple: we are asking for submissions of up to 350 words on Pharmageddon, by 31 December 2007.  The offer of prizes/grants reflects these thoughts:

     
  • The issues are vital and deserve attention: Pharmageddon implies the drug equivalent of Climate Change – or not
  •        
  • The prize money is recompense for hard work, for condensing and honing words, thinking beyond your usual box
  • Competition should stimulate participation, and make the challenge equal for passionate believers and disbelievers alike

This grant supports a project that aims to grow sufficiently to establish whether or not the risk of Pharmageddon might be real; and whether the reality is capable of being understood, in the face of perhaps implacable and overwhelming resistance.

  For further information, please see the Social Audit website for the original brief on Pharmageddon, and the subsequent Call for Abstracts and/or contact:

  Charles Medawar, Director, Social Audit Ltd on 020 7586 7771 (charles@socialaudit.org.uk)

  Dr Tim Reed, Teresa Alves or Sophie Bloemen at Health Action International (Europe) on +31 206 833 684 (info@haiweb.org)  

Pharmageddon? Evidence

 
Medicine Prices
Essential Innovation
Drug Promotion
Public Private Interactions
Conflict of interest